A detailed history of Arizona State Retirement System transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Arizona State Retirement System holds 25,486 shares of FATE stock, worth $102,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,486
Holding current value
$102,453
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$3.26 - $7.08 $83,084 - $180,440
25,486 New
25,486 $83,000
Q3 2023

Nov 06, 2023

BUY
$2.02 - $5.04 $713 - $1,779
353 Added 1.6%
22,410 $47,000
Q2 2023

Aug 01, 2023

SELL
$4.76 - $6.59 $2,222 - $3,077
-467 Reduced 2.07%
22,057 $104,000
Q1 2023

Apr 27, 2023

BUY
$4.24 - $11.12 $2,658 - $6,972
627 Added 2.86%
22,524 $128,000
Q4 2022

Feb 07, 2023

BUY
$9.86 - $23.83 $8,775 - $21,208
890 Added 4.24%
21,897 $220,000
Q3 2022

Nov 07, 2022

BUY
$21.04 - $36.06 $2,125 - $3,642
101 Added 0.48%
21,007 $471,000
Q2 2022

Jul 28, 2022

BUY
$17.78 - $42.39 $4,533 - $10,809
255 Added 1.23%
20,906 $518,000
Q1 2022

May 04, 2022

BUY
$29.67 - $60.28 $4,628 - $9,403
156 Added 0.76%
20,651 $801,000
Q4 2021

Feb 04, 2022

BUY
$47.84 - $64.34 $143 - $193
3 Added 0.01%
20,495 $1.2 Million
Q3 2021

Nov 12, 2021

BUY
$59.27 - $95.73 $5,808 - $9,381
98 Added 0.48%
20,492 $1.22 Million
Q2 2021

Aug 02, 2021

BUY
$67.25 - $92.52 $5,178 - $7,124
77 Added 0.38%
20,394 $1.77 Million
Q1 2021

May 06, 2021

BUY
$72.16 - $117.4 $12,195 - $19,840
169 Added 0.84%
20,317 $1.68 Million
Q4 2020

Jan 28, 2021

BUY
$38.09 - $100.95 $53,135 - $140,825
1,395 Added 7.44%
20,148 $1.83 Million
Q3 2020

Nov 05, 2020

BUY
$30.41 - $40.5 $155,212 - $206,712
5,104 Added 37.39%
18,753 $750,000
Q2 2020

Aug 04, 2020

SELL
$20.21 - $35.23 $11,075 - $19,306
-548 Reduced 3.86%
13,649 $468,000
Q1 2020

May 05, 2020

BUY
$17.28 - $31.88 $245,324 - $452,600
14,197 New
14,197 $315,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $390M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.